Drugs / Tumor-associated antigen-specific T cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05238792 | Nov 2021 → Oct 2028 expected | cancer | Children's National Research Institute | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tumor-associated antigen-specific T cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05238792 ↗ |
| Known as | TAA-T | “Tumor-associated antigen-specific T cell (TAA-T)” NCT05238792 ↗ |